SCHEMBL22378591

SCHEMBL22378591

N#Cc1cc(-n2c3ccccc3c3ccccc32)ccc1-c1ccc(-c2ccccc2-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
MAPK1 P28482 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ESR2 Q92731 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ATM Q13315 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NR3C1 P04150 1/20 0.36
PPARG P37231 1/20 0.35
IMPDH2 P12268 1/20 0.35
TRPA1 O75762 1/20 0.34
CYP19A1 P11511 1/20 0.33
STS P08842 1/20 0.33
ALOX5AP P20292 1/20 0.33
FEN1 P39748 1/20 0.33
AR P10275 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22377514 0.94 NR3C1 (0.37) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22377720 0.93 ALDH1A1 (0.38) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22378595 0.93 KDM4E (0.40) ALDH1A1HPGDMAPK1ESR2KDM4E
SCHEMBL22378368 0.92 SMN1; SMN2 (0.40) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL19755310 0.92 KDM4E (0.40) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22379644 0.92 STS (0.39) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22377778 0.92 NR3C1 (0.36) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22377768 0.92 STS (0.39) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22377774 0.92 ESR2 (0.36) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2
SCHEMBL22378833 0.92 STS (0.39) ALDH1A1LMNAHPGDMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
EP-3702349-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME Samsung Electronics Co., Ltd. (KR) 2020-09-02 EP disclosed
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CRY2 ALDH1A1 19/4885LMNA 3292/4885HPGD 650/4885
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CYP1A1, CRY2 ALDH1A1 19/4885LMNA 3292/4885HPGD 650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.